GHK is a tripeptide that binds copper with high affinity, and the resulting complex is one of the most studied peptides in dermatological and wound-healing research.
Key Takeaways
- The glycyl-L-histidyl-L-lysine sequence chelates Cu(II) through its histidine imidazole and terminal amine.
- The complex is hydrophilic and charged, which limits passive penetration through intact stratum corneum.
- Much of the consumer-facing literature overstates the clinical record.
Why copper binding matters
The glycyl-L-histidyl-L-lysine sequence chelates Cu(II) through its histidine imidazole and terminal amine. Copper is a cofactor for lysyl oxidase and several antioxidant enzymes, so the complex is thought to make the metal more available at the tissue level rather than acting purely as a peptide signal.
Extracellular matrix findings
In vitro work reports changes in collagen and glycosaminoglycan production in fibroblast cultures, and the peptide appears in studies of decorin and metalloproteinase activity. These are cell-culture observations; the magnitude of any effect in intact skin remains an open question.
For related mechanism work, see AOD-9604 peptide.
Topical delivery constraints
The complex is hydrophilic and charged, which limits passive penetration through intact stratum corneum. Formulation work therefore focuses on vehicle choice, penetration enhancers, and delivery formats rather than simply raising concentration.
Stability considerations
Copper complexes are sensitive to pH drift and to chelating excipients such as EDTA, which can strip the metal. Any formulation study should confirm that the complex survives the finished vehicle, not just the stock solution.
Interpreting cosmetic claims
Much of the consumer-facing literature overstates the clinical record. The defensible statement is that GHK-Cu has a substantial preclinical and a modest controlled topical literature, not that it reverses ageing.
Experimental Conditions and Practical Setup
Fibroblast studies are normally run at physiological pH in buffered saline or low-serum medium, with the copper complex formed before addition by mixing the peptide and a copper salt at roughly equimolar ratio. Any EDTA in the medium will strip the metal, and ascorbate can reduce Cu(II), so both are checked before an experiment begins.
Formulation checks specific to copper peptides
| Check | Why it matters | Typical failure |
|---|---|---|
| Chelator content | EDTA removes the bound copper | Activity lost with no visible change |
| pH range | Complex stability is pH dependent | Precipitation at alkaline pH |
| Surfactant choice | Some surfactants disrupt the complex | Reduced assay signal |
| Trace metals | Iron or zinc can compete for binding | Variable copper content between batches |
Practical Notes for the Bench
- Check that EDTA or other chelators are absent from the vehicle.
- Confirm the copper complex survives in the finished formulation, not just in stock.
- Separate fibroblast-culture findings from clinical skin outcomes.
Frequently Asked Questions
What does the copper actually do?
Copper serves as a cofactor for enzymes involved in matrix crosslinking and antioxidant defence; the peptide is thought to improve its local availability.
Does GHK-Cu penetrate intact skin?
Passive penetration is limited by its hydrophilic, charged character, which is why vehicle design matters more than concentration.
Is the clinical evidence strong?
The preclinical record is substantial, but controlled human data remain limited relative to the volume of marketing claims.
Can the complex be analysed to confirm the metal is still bound?
Yes. Mass spectrometry shows the copper adduct mass, and the characteristic visible absorbance of the complex shifts when the metal is lost. Either method is adequate for a routine check.
Related Reading
- AOD-9604 peptide
- delta sleep-inducing peptide
- KPV anti-inflammatory peptide
- GLP-1 receptor agonist peptides
- peptide water content
References & Further Reading
- Bian Y et al. The glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox Biol. 2024. PubMed 38879894
- Mehr A et al. The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography. Acta Crystallogr D Struct Biol. 2020. PubMed 33263328
- Abul-Haija YM et al. Cooperative, ion-sensitive co-assembly of tripeptide hydrogels. Chem Commun (Camb). 2017. PubMed 28805225
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- Peptide research collection at Nature
Content here is written for researchers handling peptide reagents. It does not constitute medical guidance, dosing advice, or an endorsement of any supplier.
Reviewed by Dr. Aiko Tanaka, Bioactive Peptides & Dermatological Research.